New Key Statistics Module, Z-Score and F-Score
NAS:RYTM Key Ratios
| Market Cap $ M | 2,386.48 |
| Enterprise Value $ M | 2,186.36 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 38.75 |
| Price/Sales | 24.96 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 91.00 |
| EPS (TTM) $ | -4.63 |
| Beneish M-Score | -3.73 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 1.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -8.50 |
| EV-to-EBITDA | -8.56 |
| PEG | -- |
| Shares Outstanding M | 60.97 |
| Net Margin (%) | -297.93 |
| Operating Margin % | -295.57 |
| Pre-tax Margin (%) | -296.99 |
| Quick Ratio | 4.20 |
| Current Ratio | 4.35 |
| ROA % (ttm) | -85.52 |
| ROE % (ttm) | -164.81 |
| ROIC % (ttm) | -854.52 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.43 |
RYTM Number of Guru Trades
RYTM Volume of Guru Trades
Gurus Latest Trades with NAS:RYTM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RYTM is held by these investors
Total 2
Rhythm Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:RYTM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers